ALK POSITIVE RESEARCH AWARD ON INNOVATIVE THERAPEUTIC STRATEGIES

LUNG CANCER RESEARCH FOUNDATION (LCRF)

Object

Topic: Lung cancer.

Destination: Project funding grant with a partner clinical trial, focused on the development of novel therapies, including immunotherapeutic approaches, for patients with lung tumors harboring ALK translocations.

Budget: €2M.

Duration: 3 years.

 

Are you interested in this call?

Are you interested?

Fill out the form below to receive more information: